MERCER GLOBAL ADVISORS INC /ADV
Position in CATX — Perspective Therapeutics, Inc.
CIK 853758
DENVER, CO
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$92,861
+$16,675 QoQ
Shares Held
22,269
-19.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MERCER GLOBAL ADVISORS INC /ADV holds $222,746,178 across 50 Medical Devices names. CATX ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
539,567 | $55,397,343 | |
| 2 | MDT |
Medtronic plc
|
575,118 | $49,833,974 | |
| 3 | SYK |
Stryker Corp
|
150,940 | $49,597,374 | |
| 4 | EW |
Edwards Lifesciences Corp
|
260,717 | $20,878,217 | |
| 5 | BSX |
Boston Scientific Corp
|
195,951 | $12,295,925 | |
| 6 | PODD |
Insulet Corp
|
17,306 | $3,631,491 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
305,118 | $3,319,683 | |
| 8 | DXCM |
Dexcom Inc
|
51,855 | $3,256,494 |
All Filings in CATX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,861 | 22,269 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $76,186 | 27,704 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $100,413 | 29,275 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,408 | 16,107 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,271 | 16,090 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $51,320 | 16,088 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||